Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07787507 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT07787507 · ClinicalTrials.gov record · last posted 2026-08-26

Withania Somnifera for Moderate-to-Severe Persistent Asthma

Study acronym: WISTA
StatusCompleted
PhaseNot applicable
Started2026-02-15
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
This randomized, double-blind, placebo-controlled study evaluated Withania somnifera root powder as a complementary therapy in adults with moderate-to-severe persistent asthma receiving standard asthma treatment. Participants were assigned to standard treatment alone, standard treatment plus placebo, or standard treatment plus Withania somnifera root powder for 10 weeks. Lung function, asthma control, quality of life, systemic oxidative stress, and inflammatory and allergic biomarkers were assessed before and after the intervention to evaluate the potential additional benefits of Withania somnifera in asthma management.
Trial Details
NCT Number NCT07787507
Lead Sponsor Aligarh Muslim University
Conditions Asthma
Enrollment 120 participants
Start Date 2026-02-15
Primary Completion 2026-06-15 (estimated)
Study Completion 2026-06-15 (estimated)
Updated on ClinicalTrials.gov 2026-08-26